Tag: SynAIRgy phase 3 trial
-
AD109 and the SynAIRgy Phase 3 Trial: What a Once Daily Pill Could Mean for Treating Obstructive Sleep Apnea
Obstructive sleep apnea, or OSA, affects millions of adults and often goes untreated because the most common therapy – the CPAP machine – can be uncomfortable or difficult to use every night. Many people simply cannot tolerate the mask, the noise, or the feeling of forced air. For years, researchers have been searching for an…